ArticleMikrochimica acta2025
Rapid and sensitive detection of OXA-23-mediated carbapenem resistance in Acinetobacter baumannii using a paper-based immunoassay with silver-based signal amplification.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanoyeast-based impedimetric biosensor with mutated single chain antigen-binding fragment anchoring for SARS-CoV-2 detection.Biomedical microdevices · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Increased incidence of infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) in intensive care units has necessitated the development of rapid diagnostics. Resistance is primarily caused by OXA-type carbapenemases, of which OXA-23 is the most widespread. This study describes the development of recombinant monoclonal antibodies targeting OXA-23 and their application in a paper-based assay for rapid CRAB detection. Six scFv binders were identified from an immunized phage-displayed mouse antibody library against the OXA-23 protein, of which scFv 11 and 13 exhibited high sensitivity. These clones retained their binding activity in the presence of detergent-based cell lysis buffer and demonstrated specific detection of OXA-23 with no cross-reactivity to related carbapenemases. A paper-based visual detection assay was designed using mono-biotinylated OXA scFv 11 and streptavidin-conjugated gold nanoparticles as detector molecules, with a provision for silver-based color enhancement for signal amplification. The assay enabled the detection of OXA-23-producing A. baumannii at a limit of 1 × 10⁴ CFU/ml within 30 min, from culture lysis to result interpretation. This detection limit aligns with the bacterial loads typically observed in ventilator-associated pneumonia, highlighting the suitability of the assay for clinically relevant detection. The assay showed 100% sensitivity and 100% specificity when evaluated against well-characterized clinical isolates. It offers operational ease, and clinically relevant sensitivity and specificity comparable to existing immunochromatographic platforms. The silver-based color enhancement step further improves visual identification, thereby allowing the unambiguous detection of low bacterial loads without the need for complex instrumentation. The assay is expected to facilitate early resistance detection in CRAB and improve clinical decision-making.
Indexed as
Identifiers
41251862What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.